within Pharmacolibrary.Drugs.ATC.N;

model N06BX13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.14,
    Cl             = 56 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 150 / 1000000,
    adminCount     = 1,
    Vd             = 0.008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.00027833333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Idebenone is a synthetic analog of coenzyme Q10, functioning as an antioxidant. It is primarily investigated and used for the treatment of neuromuscular disorders, most notably Leber's hereditary optic neuropathy (LHON). It is approved under the trade name Raxone in some countries for LHON, but not for other indications such as Alzheimer's disease.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adults with oral administration; limited published human PK data available.</p><h4>References</h4><ol><li><p>Becker, C, et al., &amp; Drewe, J (2010). Pharmacokinetic evaluation of idebenone. <i>Expert opinion on drug metabolism &amp; toxicology</i> 6(11) 1437–1444. DOI:<a href=&quot;https://doi.org/10.1517/17425255.2010.530656&quot;>10.1517/17425255.2010.530656</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20955109/&quot;>https://pubmed.ncbi.nlm.nih.gov/20955109</a></p></li><li><p>Bodmer, M, et al., &amp; Drewe, J (2009). Pharmacokinetics and metabolism of idebenone in healthy male subjects. <i>European journal of clinical pharmacology</i> 65(5) 493–501. DOI:<a href=&quot;https://doi.org/10.1007/s00228-008-0596-1&quot;>10.1007/s00228-008-0596-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19125241/&quot;>https://pubmed.ncbi.nlm.nih.gov/19125241</a></p></li><li><p>Di Prospero, NA, et al., &amp; Taylor, JP (2007). Safety, tolerability, and pharmacokinetics of high-dose idebenone in patients with Friedreich ataxia. <i>Archives of neurology</i> 64(6) 803–808. DOI:<a href=&quot;https://doi.org/10.1001/archneur.64.6.803&quot;>10.1001/archneur.64.6.803</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17562928/&quot;>https://pubmed.ncbi.nlm.nih.gov/17562928</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N06BX13;
